NASDAQ: PDSBPds Biotechnology Corp Stock Ownership - Who owns Pds Biotechnology?
Insider buying vs selling
Have Pds Biotechnology Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Gregory Gene Freitag | Director | 2025-02-28 | 15,060 | $1.66 | $25.00kBuy |
| Stephen C. Glover | Director | 2025-02-28 | 15,061 | $1.66 | $25.00kBuy |
PDSB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when PDSB insiders and whales buy or sell their stock.
PDSB Shareholders
What type of owners hold Pds Biotechnology Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Armistice Capital LLC | 9.67% | 4,419,000 | $7.73M | Institution |
| James Healy | 6.24% | 2,852,711 | $4.99M | Insider |
| Anders D. Hove | 4.53% | 2,068,582 | $3.62M | Insider |
| Vanguard Group Inc | 3.30% | 1,510,221 | $2.64M | Institution |
| Liam Ratcliffe | 2.59% | 1,182,434 | $2.07M | Insider |
| Kurt G. Conti | 2.44% | 1,113,961 | $1.95M | Insider |
| Delyle W. Bloomquist | 1.75% | 798,911 | $1.40M | Insider |
| Frank Beduaddo | 1.51% | 690,866 | $1.21M | Insider |
| Sol J. Barer | 1.48% | 678,075 | $1.19M | Insider |
| Brian A. Leuthner | 1.39% | 633,384 | $1.11M | Insider |
PDSB vs Biotech Stocks
Pds Biotechnology Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.